Soligenix
SNGX
#11002
Rank
HK$57.16 M
Marketcap
HK$2.63
Share price
0.51%
Change (1 day)
-75.17%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2026 (TTM): -HK$91.43 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -HK$92.88 Million a decrease over its 2024 earnings that were of -HK$73.3 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$91.43 Million-1.56%
2025 -HK$92.88 Million26.72%
2024 -HK$73.3 Million22.96%
2023 -HK$59.61 Million-45.74%
2022 -HK$0.11 Billion11.88%
2021 -HK$98.18 Million-32.37%
2020 -HK$0.15 Billion83.18%
2019 -HK$79.25 Million11.57%
2018 -HK$71.03 Million19.29%
2017 -HK$59.54 Million33%
2016 -HK$44.77 Million-19.7%
2015 -HK$55.75 Million5.16%
2014 -HK$53.02 Million
2010 -HK$59.84 Million26.12%
2009 -HK$47.45 Million75.1%
2008 -HK$27.1 Million-45.38%
2007 -HK$49.61 Million-22.84%
2006 -HK$64.29 Million66.15%
2005 -HK$38.7 Million-16.65%
2004 -HK$46.43 Million13.28%
2003 -HK$40.99 Million-11.88%
2002 -HK$46.51 Million-59.44%
2001 -HK$0.12 Billion378.18%
2000 -HK$23.98 Million-38.53%
1999 -HK$39.02 Million-18.43%
1998 -HK$47.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$146.77 B-160,056.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$54.15 B-59,115.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$56.13 B-61,279.19%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-HK$0.15 Billion 55.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-HK$0.33 Billion 256.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$12.58 B-13,813.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-HK$21.59 Million-76.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-HK$0.75 Billion 712.56%๐Ÿ‡บ๐Ÿ‡ธ USA